AOMs help patients manage postsurgical weight recurrence
Anti-obesity medications, including semaglutide (Ozempic and Wegovy), can effectively help patients manage weight regained after...
top of page
Browse by category
Search
Obesity will become the most important risk factor for heart attacks
Researchers from the National University of Singapore have predicted that the number of heart attacks in Singapore is projected to rise...
FDA warns against using compounded semaglutide
The FDA has received adverse event reports after patients used compounded semaglutide for type 2 diabetes and weight loss. Drug...
Journal Watch 31/05/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Obesity increases risk of mental disorders
Obesity diagnosis significantly increases the probability of a broad spectrum of mental disorders in all age groups m- including...
Researchers design strategy to fight obesity through gene therapy
Researchers from the University of Barcelona and CIBERobn have designed a strategy to fight obesity and diabetes in mice through ex vivo...
Body contouring does not offer clinically significant, long-term sustained weight loss benefit
For patients with massive weight loss after bariatric surgery, subsequent body contouring to remove excess skin is not itself associated...
Olympus launches POWERSEAL Sealer/Divider, a next level surgical bipolar energy device in EMEA
Olympus has announced the full market launch of POWERSEAL Sealer/Divider for the Europe, Middle East and Africa (EMEA) region. This...
Journal watch 24/05/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
B cells promote liver cancer with dangerous dual strategy
An increase in the numbers of activated B cells in the gastrointestinal tract drive inflammatory fatty liver disease (NASH, non-alcoholic...
Browse by tag
bottom of page